The influence of cationic lipid type on in-vitro release kinetic profiles of antisense oligonucleotide from cationic nanoemulsions.
Novel formulations of cationic nanoemulsions based on three different lipids were developed to strengthen the attraction of the polyanionic oligonucleotide (ODN) macromolecules to the cationic moieties on the oil nanodroplets. These formulations were developed to prolong the release of the ODN from the nanoemulsion under appropriate physiological dilutions as encountered in the eye following topical application. Increasing the concentration of the new cationic lipid exhibiting two cationic amine groups (AOA) in the emulsion from 0.05% to 0.4% did not alter markedly the particle size or zeta potential value of the blank cationic nanoemulsion. The extent of ODN association did not vary significantly when the initial concentration of ODN remained constant at 10 microM irrespective of the cationic lipid nature. However, the zeta potential value dropped consistently with the low concentrations of 0.05% and 0.1% of AOA in the emulsions suggesting that an electrostatic attraction occurred between the cationic lipids and the polyanionic ODN molecules at the o/w interface. Only the nanoemulsion prepared with N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium salts (DOTAP) remained physically stable over time. DOTAP cationic lipid nanoemulsion was the most efficient formulation capable of retaining the ODN despite the high dilution of 1:100 with simulated tear solution (STS). Less than 10% of the ODN was exchanged in contrast to 40-50% with the other cationic nanoemulsions. The in-vitro release kinetic behavior of ODN exchange with physiological anions present in the STS appears to be complex and difficult to characterize using mathematical fitting model equations. Further pharmacokinetic studies are needed to verify our kinetic assumptions and confirm the in-vitro ODN release profile from DOTAP cationic nanoemulsions.
Hagigit
Tal
T
Department of Pharmaceutics, The Hebrew University of Jerusalem, Jerusalem, Israel.
Nassar
Taher
T
Behar-Cohen
Francine
F
Lambert
Gregory
G
Benita
Simon
S
D000588:Amines / Q000737:chemistry; D002412:Cations; D004655:Emulsions; D005229:Fatty Acids, Monounsaturated / Q000737:chemistry; D018014:Gene Transfer Techniques; D007700:Kinetics; D008055:Lipids / Q000138:chemical synthesis / Q000737:chemistry*; D008956:Models, Chemical; D049329:Nanostructures; D016376:Oligonucleotides, Antisense / Q000737:chemistry* / Q000378:metabolism; D010316:Particle Size; D000644:Quaternary Ammonium Compounds / Q000737:chemistry; D012995:Solubility; D014867:Water / Q000737:chemistry
D000588:Amines; D002412:Cations; D004655:Emulsions; D005229:Fatty Acids, Monounsaturated; D008055:Lipids; D016376:Oligonucleotides, Antisense; D000644:Quaternary Ammonium Compounds; D014867:Water; C070046:1,2-dioleoyloxy-3-(trimethylammonium)propane; C008703:oleylamine